ANGIODYNAMICS INC — Director's Dealing 2019

Aug 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2019-07-12

Reporting Person: Campbell Chad Thomas (SVP/GM, Vascular Access)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-12	Common Stock	M	3174	—	Acquired	22102	Direct
2019-07-12	Common Stock	F	1050	$21.68	Disposed	21052	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-12	Performance right	$	M	6103	Disposed		Common Stock (6103)	Direct

Footnotes

F1: This acquisition of 3,174 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 27, 2016.

F2: The exempt disposition of 1,050 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 27, 2016.

F3: On July 27, 2016, the reporting person received a target grant of 6,103 performance share units vesting between 0% and 200%. The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019. Based on the Company's performance over this period, 3,174 shares of Common Stock were issued to the reporting person under this grant.